The potential impact on clinical practice of differences in the in-vitro activity of vancomycin and teicoplanin.
Cheesbrough
J S
JS
Smith
S R
SR
Davies
J M
JM
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001424:Bacterial Infections / Q000188:drug therapy*; D006020:Glycopeptides / Q000494:pharmacology; D006801:Humans; D008826:Microbial Sensitivity Tests; D017334:Teicoplanin; D014640:Vancomycin / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D017334:Teicoplanin; D014640:Vancomycin